241 related articles for article (PubMed ID: 9155516)
21. Prostate cancer: screening and early detection.
Tariman JD
Adv Nurse Pract; 2006 Sep; 14(9):20. PubMed ID: 16972436
[No Abstract] [Full Text] [Related]
22. AUA issues a policy report on PSA monitoring. The American Urological Association.
Scott Morey S
Am Fam Physician; 2000 Aug; 62(4):883-4. PubMed ID: 10969861
[No Abstract] [Full Text] [Related]
23. PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.
Greiver M; Rosen N
CMAJ; 2000 Mar; 162(6):789-90. PubMed ID: 10750465
[No Abstract] [Full Text] [Related]
24. [PSA based screening for prostatic cancer].
Johansen TE
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
[No Abstract] [Full Text] [Related]
25. Prostatic specific antigen in prostate cancer.
Wozniak-Petrofsky J
Urol Nurs; 1992 Sep; 12(3):104-5. PubMed ID: 1382317
[No Abstract] [Full Text] [Related]
26. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
[No Abstract] [Full Text] [Related]
27. How valuable is prostate-specific antigen screening?
Handler S
Minn Med; 1996 Jun; 79(6):2. PubMed ID: 8692130
[No Abstract] [Full Text] [Related]
28. Prostate cancer--more information and more questions.
Dall'Era M; Carroll PR
J Urol; 2007 May; 177(5):1607-8. PubMed ID: 17437768
[No Abstract] [Full Text] [Related]
29. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.
Höltl W; Lunglmayr G
Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868
[No Abstract] [Full Text] [Related]
30. Prostate cancer--the snowball is rolling.
Ruutu M; Salo J; Nordling S; Rannikko S
Ann Chir Gynaecol; 1999; 88(1):5-8. PubMed ID: 10230675
[No Abstract] [Full Text] [Related]
31. Prostate cancer screening.
Catalona WJ
BJU Int; 2004 Nov; 94(7):964-6. PubMed ID: 15541107
[No Abstract] [Full Text] [Related]
32. Does screening with prostate/specific antigen improve outcomes?
Ohrt D
Minn Med; 1996 Apr; 79(4):50-1. PubMed ID: 8637494
[No Abstract] [Full Text] [Related]
33. [Screening for prostate cancer: results from the first screening round in the French population of the ERSPC trial].
Richard F
Prog Urol; 2009 Jul; 19(7):499-500. PubMed ID: 19559381
[No Abstract] [Full Text] [Related]
34. Prostate cancer: current evidence weighs against population screening.
Boyle P; Brawley OW
CA Cancer J Clin; 2009; 59(4):220-4. PubMed ID: 19564244
[No Abstract] [Full Text] [Related]
35. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
Bratt O; Björk T
Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615
[No Abstract] [Full Text] [Related]
36. A risk-stratified approach to prostate-specific antigen screening.
Keto CJ; Freedland SJ
Eur Urol; 2011 Apr; 59(4):506-8. PubMed ID: 21292387
[No Abstract] [Full Text] [Related]
37. Tumour markers in prostate cancer: EGTM recommendations. European Group on Tumour Markers.
Anticancer Res; 1999; 19(4A):2799-801. PubMed ID: 10470244
[No Abstract] [Full Text] [Related]
38. [Detection of prostate cancer: yes or no?].
Van Cangh PJ
Bull Mem Acad R Med Belg; 2006; 161(3-4):159-69. PubMed ID: 17172224
[No Abstract] [Full Text] [Related]
39. [Screening in prostate carcinoma].
Wirth MP; Spiegel T; Froschermaier SE; Manseck A
Z Arztl Fortbild Qualitatssich; 1998 Jun; 92(5):304-9. PubMed ID: 9702818
[TBL] [Abstract][Full Text] [Related]
40. Early stage prostate cancer--do we have a problem with over-detection, overtreatment or both?
Carroll PR
J Urol; 2005 Apr; 173(4):1061-2. PubMed ID: 15758699
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
